Autoimmune hyperphosphatemic tumoral calcinosis in a patient with FGF23 autoantibodies

Luciferase immunoprecipitation systems for measuring antibodies in autoimmune and infectious diseases

(2015) Peter D. Burbelo et al.   Translational Research

Immune dysregulation in human subjects with heterozygous germline mutations in CTLA4

(2014) H. S. Kuehn et al.   SCIENCE

Chronic Inhibition of ERK1/2 Signaling Improves Disordered Bone and Mineral Metabolism in Hypophosphatemic (Hyp) Mice

(2012) Martin Y. H. Zhang et al.   ENDOCRINOLOGY

Tumor-induced osteomalacia

(2011) William H Chong et al.   ENDOCRINE-RELATED CANCER

Fibroblast growth factor 23 regulates renal 1,25-dihydroxyvitamin D and phosphate metabolism via the MAP kinase signaling pathway in Hyp mice

(2011) Daniel Ranch et al.   JOURNAL OF BONE AND MINERAL RESEARCH

PLA2R Autoantibodies and PLA2R Glomerular Deposits in Membranous Nephropathy

(2011) Hanna Debiec et al.   NEW ENGLAND JOURNAL OF MEDICINE

Complement receptor 2/CD21- human naive B cells contain mostly autoreactive unresponsive clones

(2010) I. Isnardi et al.   BLOOD

Comparison of Radioimmunoprecipitation With Luciferase Immunoprecipitation for Autoantibodies to GAD65 and IA-2 

(2010) P. D. Burbelo et al.   DIABETES CARE

A New Luminescence Assay for Autoantibodies to Mammalian Cell-Prepared Insulinoma-Associated Protein 2

(2008) P. D. Burbelo et al.   DIABETES CARE

A case of familial tumoral calcinosis/hyperostosis–hyperphosphatemia syndrome due to a compound heterozygous mutation in GALNT3 demonstrating new phenotypic features

(2008) C. E. Dumitrescu et al.   OSTEOPOROSIS INTERNATIONAL